Apellis Pharmaceuticals Inc Média de recomendação
Qual é o Média de recomendação de Apellis Pharmaceuticals Inc?
O Média de recomendação de Apellis Pharmaceuticals Inc é 1.43
Qual é a definição de Média de recomendação?
A média da recomendação é a média das classificações dos analistas das ações, variando de 1,0 (compra forte) a 5,0 (venda forte).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Média de recomendação de empresas na Setor Health Care em NASDAQ em comparação com Apellis Pharmaceuticals Inc
O que Apellis Pharmaceuticals Inc faz?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Empresas com média de recomendação semelhantes a Apellis Pharmaceuticals Inc
- LHC Inc tem Média de recomendação de 1.42
- Imax Corp tem Média de recomendação de 1.42
- TAL Education tem Média de recomendação de 1.42
- Coherent Corp tem Média de recomendação de 1.42
- Canadian Natural Resources tem Média de recomendação de 1.42
- Semtech tem Média de recomendação de 1.42
- Apellis Pharmaceuticals Inc tem Média de recomendação de 1.43
- Addus HomeCare tem Média de recomendação de 1.44
- Biolife Solutions Inc tem Média de recomendação de 1.44
- Visa Inc tem Média de recomendação de 1.44
- ServiceNow Inc tem Média de recomendação de 1.44
- Daqo New Corp tem Média de recomendação de 1.44
- ACM Research Inc tem Média de recomendação de 1.44